Paper6090280
Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.
Quatrini M and 2 others. Gut, 1984. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study. Papers, record 6090280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6090280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Duodenal Ulcer | Major topic |
| Ranitidine | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Chronic Disease | |
| Clinical Trials as Topic | |
| Drug Resistance | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Random Allocation | |
| Stomach |
Source PubMed
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 340325 | Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. | Gastroenterology | 1978 | https://conductscience.org/library/papers/340325 | PubMed |
| 2 | 365665 | Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. | Gastroenterology | 1979 | https://conductscience.org/library/papers/365665 | PubMed |
| 3 | 456231 | Effects of long-term cimetidine on serum gastrin in duodenal ulcer. | Dig Dis Sci | 1979 | https://conductscience.org/library/papers/456231 | PubMed |
| 4 | 468071 | Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. | Gut | 1979 | https://conductscience.org/library/papers/468071 | PubMed |
| 5 | 6109102 | Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. | Lancet | 1981 | https://conductscience.org/library/papers/6109102 | PubMed |
| 6 | 6113192 | Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer. | Gut | 1981 | https://conductscience.org/library/papers/6113192 | PubMed |
| 7 | 6118237 | The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist. | Curr Med Res Opin | 1981 | https://conductscience.org/library/papers/6118237 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8093870 | Bleeding duodenal ulcer. Role of gastric acid hypersecretion. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8093870 | PubMed |
| 3604233 | The refractory ulcer. | World J Surg | 1987 | https://conductscience.org/library/papers/3604233 | PubMed |
| 3356359 | Risk factors for healing of duodenal ulcer under antacid treatment: do ulcer patients need individual treatment? | Gut | 1988 | https://conductscience.org/library/papers/3356359 | PubMed |
| 3308650 | Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. | Gut | 1987 | https://conductscience.org/library/papers/3308650 | PubMed |
| 3113079 | Peptic ulcer disease. Pathophysiology and current medical management. | West J Med | 1987 | https://conductscience.org/library/papers/3113079 | PubMed |
| 2914544 | Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). | Dig Dis Sci | 1989 | https://conductscience.org/library/papers/2914544 | PubMed |
| 2904675 | Resistant duodenal ulcer: when, why and what to do? | Postgrad Med J | 1988 | https://conductscience.org/library/papers/2904675 | PubMed |
| 2680793 | Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. | Gut | 1989 | https://conductscience.org/library/papers/2680793 | PubMed |
| 2667937 | Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases. | Drugs | 1989 | https://conductscience.org/library/papers/2667937 | PubMed |
| 2567661 | Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease. | Drugs | 1989 | https://conductscience.org/library/papers/2567661 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GAST | 2520 | PubTator's text mining | https://conductscience.org/library/genes/2520 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6090280
GET https://conductscience.org/api/papers/v1/6090280/authors